Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes - PubMed (original) (raw)
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
Shelley Lindley et al. Diabetes. 2005 Jan.
Abstract
Type 1 diabetes is a T-cell-mediated disease that is associated with loss of immunological tolerance to self-antigens. The mechanisms involved in maintenance of peripheral tolerance include a specialized subset of regulatory T-cells (Treg) within the CD4(+)CD25(+) T-cell population, but the function and phenotype of these cells in type 1 diabetes have not been investigated. We hypothesized that a deficiency in the CD4(+)CD25(+) Treg population or its function could contribute to the lack of self-tolerance evident in patients with type 1 diabetes. We show that although levels of CD4(+)CD25(+) T-cells are normal in patients with recent-onset adult type 1 diabetes, the ability of the Tregs in this population to suppress T-cell proliferation during in vitro cocultures is markedly reduced compared with control subjects (P = 0.007). Moreover, in patients with type 1 diabetes, these cocultures display a more proinflammatory phenotype, with increased secretion of interferon-gamma (P = 0.005) and decreased interleukin-10 production (P = 0.03). These deficiencies may reflect a disturbance in the balance of the CD4(+)CD25(+) population, because in patients with type 1 diabetes, a higher proportion of these cells coexpress the early activation marker CD69 (P = 0.007) and intracellular CTLA-4 (P = 0.01). These data demonstrate deficiency in function of the CD4(+)CD25(+) Treg population that may influence the pathogenesis of type 1 diabetes.
Similar articles
- Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
Vasu C, Prabhakar BS, Holterman MJ. Vasu C, et al. J Immunol. 2004 Aug 15;173(4):2866-76. doi: 10.4049/jimmunol.173.4.2866. J Immunol. 2004. PMID: 15295006 - Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC, Roncarolo MG. Levings MK, et al. J Exp Med. 2002 Nov 18;196(10):1335-46. doi: 10.1084/jem.20021139. J Exp Med. 2002. PMID: 12438424 Free PMC article. - Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
Park HB, Paik DJ, Jang E, Hong S, Youn J. Park HB, et al. Int Immunol. 2004 Aug;16(8):1203-13. doi: 10.1093/intimm/dxh123. Epub 2004 Jul 5. Int Immunol. 2004. PMID: 15237111 - A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop.
Tree TI, Roep BO, Peakman M. Tree TI, et al. Ann N Y Acad Sci. 2006 Oct;1079:9-18. doi: 10.1196/annals.1375.002. Ann N Y Acad Sci. 2006. PMID: 17130526 Review. - The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells.
Boden E, Tang Q, Bour-Jordan H, Bluestone JA. Boden E, et al. Novartis Found Symp. 2003;252:55-63; discussion 63-6, 106-14. doi: 10.1002/0470871628.ch5. Novartis Found Symp. 2003. PMID: 14609212 Review.
Cited by
- Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.
Grebinoski S, Pieklo G, Zhang Q, Visperas A, Cui J, Goulet J, Xiao H, Brunazzi EA, Cardello C, Herrada AA, Das J, Workman CJ, Vignali DAA. Grebinoski S, et al. J Immunol. 2024 Sep 15;213(6):779-794. doi: 10.4049/jimmunol.2300216. J Immunol. 2024. PMID: 39109924 - Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes.
Honardoost MA, Adinatha A, Schmidt F, Ranjan B, Ghaeidamini M, Arul Rayan N, Gek Liang Lim M, Joanito I, Xiao Xuan Lin Q, Rajagopalan D, Qi Mok S, Hwang YY, Larbi A, Khor CC, Foo R, Boehm BO, Prabhakar S. Honardoost MA, et al. Genome Med. 2024 Mar 27;16(1):45. doi: 10.1186/s13073-024-01300-z. Genome Med. 2024. PMID: 38539228 Free PMC article. - Multiply restimulated human cord blood-derived Tregs maintain stabilized phenotype and suppressive function and predict their therapeutic effects on autoimmune diabetes.
Bi Y, Kong R, Peng Y, Cai D, Zhang Y, Yang F, Li X, Deng W, Liu F, He B, Cao C, Deng C, Tang X, Fan L, Yu H, Zhou Z. Bi Y, et al. Diabetol Metab Syndr. 2024 Mar 21;16(1):71. doi: 10.1186/s13098-024-01277-0. Diabetol Metab Syndr. 2024. PMID: 38515175 Free PMC article. - Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?
Hardtke-Wolenski M, Landwehr-Kenzel S. Hardtke-Wolenski M, et al. Mol Cell Pediatr. 2024 Mar 20;11(1):3. doi: 10.1186/s40348-024-00176-8. Mol Cell Pediatr. 2024. PMID: 38507159 Free PMC article. Review. - Improving regulatory T cell production through mechanosensing.
Shi L, Lim JY, Kam LC. Shi L, et al. J Biomed Mater Res A. 2024 Jul;112(7):1138-1148. doi: 10.1002/jbm.a.37702. Epub 2024 Mar 7. J Biomed Mater Res A. 2024. PMID: 38450935
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials